|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
FLAG-tag, or FLAG octapeptide, is a polypeptide protein tag that can be added to a protein using recombinant DNA technology. It can be used for affinity chromatography, then used to separate recombinant, overexpressed protein from wild-type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits.
A FLAG-tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a FLAG-tag to this protein allows one to follow the protein with an antibody against the FLAG sequence. Examples are cellular localization studies by immunofluorescence or detection by SDS PAGE protein electrophoresis.
The peptide sequence of the FLAG-tag from the N-terminus to the C-terminus is: DYKDDDDK (1012 Da). It can be used in conjunction with other affinity tags, for example a polyhistidine tag (His-tag), HA-tag or Myc-tag. It can be fused to the C-terminus or the N-terminus of a protein. Some commercially available antibodies (e.g., M1/4E11) recognize the epitope only when it is present at the N-terminus. However, other available antibodies (e.g., M2) are position-insensitive.
|Human ACPP ORF mammalian expression plasmid, C-GFPSpark tag||HG10959-ACG|
|Human ACPP ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10959-ACR|
|Human ACPP ORF mammalian expression plasmid, C-Flag tag||HG10959-CF|
|Human ACPP ORF mammalian expression plasmid, C-His tag||HG10959-CH|
|Human ACPP ORF mammalian expression plasmid, C-Myc tag||HG10959-CM|
|Human ACPP ORF mammalian expression plasmid, C-HA tag||HG10959-CY|
|Human ACPP Gene cDNA clone plasmid||HG10959-M|
|Human ACPP ORF mammalian expression plasmid, Flag tag||HG10959-M-F|
|Human ACPP ORF mammalian expression plasmid, N-Flag tag||HG10959-NF|
|Human ACPP ORF mammalian expression plasmid, N-His tag||HG10959-NH|
|Human ACPP ORF mammalian expression plasmid, N-Myc tag||HG10959-NM|
|Human ACPP ORF mammalian expression plasmid, N-HA tag||HG10959-NY|
|Human ACPP natural ORF mammalian expression plasmid||HG10959-UT|
|Learn more about expression Vectors|
Prostatic acid phosphatase (PAP, or ACPP), also known as prostatic specific acid phosphatase (PSAP), is an enzyme produced by the prostate. As a non-specific phosphomonoesterase, Prostatic acid phosphatase synthetized and secreted into seminal plasma under androgenic control. The enzyme is a dimer of molecular weight around 100 kDa. Prostatic acid phosphatase is a clinically important protein for its relevance as a biomarker of prostate carcinoma. Furthermore, it has a potential role in fertilization. The major action of PAP is to dephosphorylate macromolecules with the help of catalytic residues (His(12) and Asp(258)) that are located in the cleft between two domains. Cellular prostatic acid phosphatase (cPAcP), an authentic tyrosine phosphatase, is proposed to function as a negative growth regulator of prostate cancer (PCa) cells in part through its dephosphorylation of ErbB-2. cPAcP functions as a neutral protein tyrosine phosphatase (PTP) in prostate cancer cells and dephosphorylates HER-2/ErbB-2/Neu (HER-2: human epidermal growth factor receptor-2) at the phosphotyrosine (p-Tyr) residues. Injection of the secretory isoform of PAP has potent antinociceptive effects in mouse models of chronic pain. This enzyme exhibits ecto-5'-nucleotidase activity, is widely distributed, and implicated in the formation of chronic pain. Additionally, PAP could be a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomas including colon and gastric cancers.